Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, updating the site revision from the previous v3.5.3. This indicates a software/version update rather than a change to the study data or layout.
    Difference
    0.0%
    Check dated 2026-05-15T05:52:00.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision changed from v3.5.2 to v3.5.3 on the page, indicating a deployed update to the study entry. This version bump does not modify the study information presented to users.
    Difference
    0.0%
    Check dated 2026-04-30T18:36:03.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to study data, eligibility criteria, or page navigation.
    Difference
    0.0%
    Check dated 2026-04-16T10:43:51.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:56:05.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:23:32.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:01:02.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.